Ilya M. Rachman

CIK: 0001889334

Transaction Breakdown

Open Market Buys (P)3 (60.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMMX

Immix Biopharma, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

IMMX
Immix Biopharma, Inc.
May 22, 2026
Award(A)
Stock Option (Right to Buy)
Direct
500K shares-
IMMX
Immix Biopharma, Inc.
Dec 10, 2025
Purchase(P)
Direct
746 shares at avg. $6.67$5K
IMMX
Immix Biopharma, Inc.
Sep 17, 2025
Purchase(P)
Direct
2.5K shares at avg. $2.02$5K
IMMX
Immix Biopharma, Inc.
Jun 20, 2025
Award(A)
Stock Option (Right to Buy)
Direct
340K shares-
IMMX
Immix Biopharma, Inc.
Jun 18, 2025
Purchase(P)
Direct
2.2K shares at avg. $2.29$5K

		Type	Shares	Price		Ownership
May 22, 2026	IMMX Immix Biopharma, Inc.	Award(A) Stock Option (Right to Buy)	500,000	-	-	Direct
Dec 10, 2025	IMMX Immix Biopharma, Inc.	Purchase(P)	746	$6.67	$4,976	Direct
Sep 17, 2025	IMMX Immix Biopharma, Inc.	Purchase(P)	2,500	$2.02	$5,050	Direct
Jun 20, 2025	IMMX Immix Biopharma, Inc.	Award(A) Stock Option (Right to Buy)	340,000	-	-	Direct
Jun 18, 2025	IMMX Immix Biopharma, Inc.	Purchase(P)	2,178	$2.29	$4,999	Direct

1-5 of 5 transactions

About Rachman Ilya M

Rachman Ilya M (SEC CIK 0001889334) files insider reports with the SEC as CEO and Chairman of Immix Biopharma, Inc. (IMMX).

Signal8 holds 5 ownership filings by Rachman Ilya M, all Form 4s, filed between Jun 20, 2025 and May 29, 2026. Those filings report 5 transactions, from Jun 18, 2025 to May 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rachman Ilya M's filings is in LOS ANGELES, CA.

Recent filings by Rachman Ilya M

May 22, 2026: Grant or award of IMMX derivative securities (Form 4, code A).
Dec 10, 2025: Open-market purchase of IMMX shares (Form 4, code P).
Sep 17, 2025: Open-market purchase of IMMX shares (Form 4, code P).
Jun 20, 2025: Grant or award of IMMX derivative securities (Form 4, code A).
Jun 18, 2025: Open-market purchase of IMMX shares (Form 4, code P).

Other insiders filing for Immix Biopharma, Inc. (IMMX)

Adams Helen C., Director
Ng Carey, Director
Marquet Magda, Director
Morris Gabriel S, CFO, President
CHANG NANCY T, Director
Chudnovsky Yekaterina, Director

How to read Form 4 transaction codes